# High Roller Technologies, Inc.: financial statements, quarterly

ROLR · NYSE · CIK 1947210 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rolr.md) · [Financials](/companies/rolr/financials.md) · [Filings](/companies/rolr/filings.md) · [Insiders](/companies/rolr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rolr/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [7,569](/filings/0001437749-24-036702.md) | [7,191 d](/filings/0001437749-25-008652.md) | [6,507](/filings/0001437749-25-017174.md) | [5,803](/filings/0001437749-25-026181.md) | [7,516](/filings/0001753926-25-001732.md) | [3,380 d](/filings/0001753926-26-000462.md) | [5,195](/filings/0001753926-26-001959.md) | [5,801](/filings/0001753926-26-001960.md) | [6,281](/filings/0001753926-25-001732.md) | [465 d](/filings/0001753926-26-000462.md) | [3,366](/filings/0001753926-26-001959.md) | [2,809](/filings/0001753926-26-001960.md) |
| Operating income | $k | [(185)](/filings/0001437749-24-036702.md) | [(1,734) d](/filings/0001437749-25-008652.md) | [(1,825)](/filings/0001437749-25-017174.md) | [(1,480)](/filings/0001437749-25-026181.md) | [(474)](/filings/0001753926-25-001732.md) | [(4,709) d](/filings/0001753926-26-000462.md) | [(3,661)](/filings/0001753926-26-001959.md) | [(1,067)](/filings/0001753926-26-001960.md) | [80.0](/filings/0001753926-25-001732.md) | [(2,543) d](/filings/0001753926-26-000462.md) | [(1,993)](/filings/0001753926-26-001959.md) | [(2,471)](/filings/0001753926-26-001960.md) |
| Interest expense | $k | not reported | not reported | [26.0](/filings/0001437749-25-017174.md) | [24.0](/filings/0001437749-25-026181.md) | [27.0](/filings/0001753926-25-001732.md) | [47.0 d](/filings/0001753926-26-000462.md) | [46.0](/filings/0001753926-26-001959.md) | [53.0](/filings/0001753926-26-001960.md) | [55.0](/filings/0001753926-25-001732.md) | [(80.0) d](/filings/0001753926-26-000462.md) | [(46.0)](/filings/0001753926-26-001959.md) | [(145)](/filings/0001753926-26-001960.md) |
| Income tax | $k | [9.0](/filings/0001437749-24-036702.md) | [4.4 d](/filings/0001437749-25-008652.md) | [0.0](/filings/0001437749-25-017174.md) | [0.0](/filings/0001437749-25-026181.md) | [0.0](/filings/0001753926-25-001732.md) | [7.0 d](/filings/0001753926-26-000462.md) | [17.0](/filings/0001753926-26-001959.md) | [37.0](/filings/0001753926-26-001960.md) | [(3,642)](/filings/0001753926-25-001732.md) | [646 d](/filings/0001753926-26-000462.md) | [16.0](/filings/0001753926-26-001959.md) | [31.0](/filings/0001753926-26-001960.md) |
| Net income | $k | [(208)](/filings/0001437749-24-036702.md) | [(1,722) d](/filings/0001437749-25-008652.md) | [(1,849)](/filings/0001753926-25-001732.md) | [(1,504)](/filings/0001753926-25-001732.md) | [(501)](/filings/0001753926-25-001732.md) | [(2,069) d](/filings/0001753926-26-000462.md) | [(3,276)](/filings/0001753926-26-001960.md) | [(592)](/filings/0001753926-26-001960.md) | [3,667](/filings/0001753926-25-001732.md) | [3,362 d](/filings/0001753926-26-000462.md) | [(1,963)](/filings/0001753926-26-001960.md) | [(2,370)](/filings/0001753926-26-001960.md) |
| Diluted EPS | $ per share | [(0.03)](/filings/0001437749-24-036702.md) | not reported | [(0.26)](/filings/0001437749-25-017174.md) | [(0.21)](/filings/0001437749-25-026181.md) | [(0.07)](/filings/0001753926-25-001732.md) | not reported | [(0.39)](/filings/0001753926-26-001959.md) | [(0.07)](/filings/0001753926-26-001960.md) | [0.39](/filings/0001753926-25-001732.md) | not reported | [(0.19)](/filings/0001753926-26-001959.md) | [(0.22)](/filings/0001753926-26-001960.md) |
| Basic EPS | $ per share | [(0.03)](/filings/0001437749-24-036702.md) | not reported | [(0.26)](/filings/0001437749-25-017174.md) | [(0.21)](/filings/0001437749-25-026181.md) | [(0.07)](/filings/0001753926-25-001732.md) | not reported | [(0.39)](/filings/0001753926-26-001959.md) | [(0.07)](/filings/0001753926-26-001960.md) | [0.43](/filings/0001753926-25-001732.md) | not reported | [(0.19)](/filings/0001753926-26-001959.md) | [(0.22)](/filings/0001753926-26-001960.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [2.1](/filings/0001437749-25-008652.md) | not reported | not reported | [1.3](/filings/0001437749-24-036702.md) | [6.9](/filings/0001753926-26-000462.md) | [3.5](/filings/0001437749-25-017174.md) | [2.7](/filings/0001437749-25-026181.md) | [2.7](/filings/0001753926-25-001732.md) | [2.1](/filings/0001753926-26-001960.md) | [22.5](/filings/0001753926-26-001959.md) | [18.0](/filings/0001753926-26-001960.md) |
| Current assets | $m | not reported | [4.9](/filings/0001437749-25-008652.md) | not reported | not reported | [3.9](/filings/0001437749-24-036702.md) | [8.8](/filings/0001753926-26-000462.md) | [5.3](/filings/0001437749-25-017174.md) | [3.9](/filings/0001437749-25-026181.md) | [3.9](/filings/0001753926-25-001732.md) | [5.8](/filings/0001753926-26-001960.md) | [26.5](/filings/0001753926-26-001959.md) | [22.5](/filings/0001753926-26-001960.md) |
| Total assets | $m | not reported | [11.8](/filings/0001437749-25-008652.md) | not reported | not reported | [12.9](/filings/0001437749-24-036702.md) | [16.6](/filings/0001753926-26-000462.md) | [12.8](/filings/0001437749-25-017174.md) | [12.3](/filings/0001437749-25-026181.md) | [16.0](/filings/0001753926-25-001732.md) | [18.5](/filings/0001753926-26-001960.md) | [39.3](/filings/0001753926-26-001959.md) | [36.7](/filings/0001753926-26-001960.md) |
| Current liabilities | $m | not reported | [9.5](/filings/0001437749-25-008652.md) | not reported | not reported | [12.7](/filings/0001437749-24-036702.md) | [10.2](/filings/0001753926-26-000462.md) | [9.3](/filings/0001437749-25-017174.md) | [8.9](/filings/0001437749-25-026181.md) | [8.7](/filings/0001753926-25-001732.md) | [7.2](/filings/0001753926-26-001960.md) | [6.1](/filings/0001753926-26-001959.md) | [5.4](/filings/0001753926-26-001960.md) |
| Total liabilities | $m | not reported | [9.5](/filings/0001437749-25-008652.md) | not reported | not reported | [13.7](/filings/0001437749-24-036702.md) | [10.9](/filings/0001753926-26-000462.md) | [10.0](/filings/0001437749-25-017174.md) | [9.7](/filings/0001437749-25-026181.md) | [9.5](/filings/0001753926-25-001732.md) | [8.9](/filings/0001753926-26-001960.md) | [7.8](/filings/0001753926-26-001959.md) | [7.1](/filings/0001753926-26-001960.md) |
| Shareholders' equity | $m | [3.8](/filings/0001437749-24-036702.md) | [2.3](/filings/0001753926-26-000462.md) | [0.9](/filings/0001753926-25-001732.md) | [(0.5)](/filings/0001753926-25-001732.md) | [(0.8)](/filings/0001753926-25-001732.md) | [5.7](/filings/0001753926-26-001960.md) | [2.8](/filings/0001753926-26-001960.md) | [2.6](/filings/0001753926-26-001960.md) | [6.6](/filings/0001753926-25-001732.md) | [9.6](/filings/0001753926-26-001960.md) | [31.5](/filings/0001753926-26-001960.md) | [29.6](/filings/0001753926-26-001960.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [183 d](/filings/0001437749-25-008652.md) | [(260)](/filings/0001437749-25-017174.md) | [(870) d](/filings/0001437749-25-026181.md) | [(225) d](/filings/0001753926-25-001732.md) | [(2,551) d](/filings/0001753926-26-000462.md) | [(3,608)](/filings/0001753926-26-001959.md) | [(840) d](/filings/0001753926-26-001960.md) | [(78.0) d](/filings/0001753926-25-001732.md) | [1,293 d](/filings/0001753926-26-000462.md) | [(2,991)](/filings/0001753926-26-001959.md) | [(2,882) d](/filings/0001753926-26-001960.md) |
| Capital expenditure | $k | [162 d](/filings/0001437749-25-008652.md) | [72.0](/filings/0001437749-25-017174.md) | [26.0 d](/filings/0001437749-25-026181.md) | [77.0 d](/filings/0001753926-25-001732.md) | [12.0 d](/filings/0001753926-26-000462.md) | [13.0](/filings/0001753926-26-001959.md) | [5.0 d](/filings/0001753926-26-001960.md) | [12.0 d](/filings/0001753926-25-001732.md) | [21.0 d](/filings/0001753926-26-000462.md) | [1.0](/filings/0001753926-26-001959.md) | [2.0 d](/filings/0001753926-26-001960.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [7.0](/filings/0001437749-24-036702.md) | [7.0](/filings/0001437749-25-017174.md) | [7.0](/filings/0001437749-25-026181.md) | [7.0](/filings/0001753926-25-001732.md) | [8.4](/filings/0001753926-26-001959.md) | [8.4](/filings/0001753926-26-001960.md) | [9.5](/filings/0001753926-25-001732.md) | [10.4](/filings/0001753926-26-001959.md) | [10.9](/filings/0001753926-26-001960.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,020,628 at 2026-10-12, from the cover of the [10-Q/A filed 2026-10-16](/filings/0001753926-26-001960.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.